Misoprostol (Cytotec)

ISSN 0256-5004 (Print)

AIMS Journal Vol 13 No 3

IMPORTANT DRUG WARNING CONCERNING UNAPPROVED USE OF INTRAVAGINAL OR ORAL MISOPROSTOL IN PREGNANT WOMEN FOR INDUCTION OR LABOR OR ABORTION

August 23, 2000
Re: Cytotec (misoprostol)

Dear Health Care Practitioner:

The purpose of this letter is to remind you that Cytotec administration by any route is contraindicated in women who are pregnant because it can cause abortion. Cytotec is not approved for the induction of labor or abortion.

Cytotec is indicated for the prevention of NSAID (nonsteroidal anti- inflammatory drugs, including aspirin) - induced gastric ulcers in patients at high risk of complications from gastric ulcer, eg the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer.

The uterotonic effect of cytotec is an inherent property of prostaglandin E1 (PGE1), of which Cytotec is a stable, orally active, synthetic analog. Searle has become aware of some instances where Cytotec, outside of its approved indication, was used as a cervical ripening agent prior to termination of pregnancy, or for induction of labor, in spite of the specific contraindications to its use during pregnancy.

Serious adverse events reported following off-label use of Cytotec in pregnant women include maternal or fetal death; uterine hyperstimulation, rupture or perforation requiring uterine surgical repair, hysterectomy or salpingo-oophorectomy, amniotic fluid embolism, severe vaginal bleeding, retained placenta, shock, fetal bradycardia and pelvic pain.

Searle has not conducted research concerning the use of Cytotec for cervical ripening prior to termination of pregnancy or for induction of labor, nor does Searle intend to study or support these uses. Therefore, Searle is unable to provide risk information for Cytotec when it is used for such purposes. In addition to the known and unknown acute risks to the mother and fetus, the effect of Cytotecon the later growth, development and functional maturation of the child when Cytotec is used for induction of labor or cervical ripening has not been established.

Searle promotes the use of Cytotec only for its approved indication. Please read the enclosed updated complete Prescribing Information for Cytotec.

Further information may be obtained by calling 1-800-323-4204.

Michael Cullen MD
Medical Director, US
Searle

Latest Content

Journal

« »

Book Review: Misconceptions: Truth,…

Complete list of book reviews on the AIMS website AIMS Journal, 2019, Vol 31, No 1 Reviewed for AIMS by Marein Schmitthenner Published by Vintage, 2002 ISBN 0-099-27416-7…

Read more

Obituary of Philomena Canning, Sept…

AIMS Journal, 2019, Vol 31, No 1 By Marie O’Connor Philomena Canning was a fearless advocate of the human rights of mothers in maternity care and of midwives in clinical…

Read more

Clinical Guidelines: Litigation, Pa…

AIMS Journal, 2019, Vol 31, No 1 By Beth Whitehead The purpose of the conference was to explore how evidence-based clinical guidelines are used by defendants, lawyers and…

Read more

Events

« »

AIMS Volunteers Meeting

Details TBC

Read more

UNICEF Baby Friendly Initiative 201…

28 - 29 November 2019, SEC Centre Glasgow Speakers include: Day 1 Dr Chris van Tulleken – Doctor and leading BBC science presenter Robert Boyle – Clinical Reader in Paedi…

Read more

International Maternity Expo

A two day (12 and 13 November) international maternity festival and trade expo from the producers of All4Maternity , The Practising Midwife and Maternity & Midwifery Foru…

Read more

Latest Campaigns

« »

Letter to The Guardian in response…

Sent 9th May 2019 By email ( guardian.readers@theguardian.com ) Dear Sir, I write in response to the opinion piece by Barbara Ellen entitled “Meghan Markle’s home birth s…

Read more

AIMS Response to MBRRACE-UK Report…

Download PDF MBRRACE-UK: Saving Lives, Improving Mothers’ Care MBRRACE-UK: Perinatal Mortality Surveillance report for births in 2016 www.npeu.ox.ac.uk/mbrrace-uk/reports…

Read more

Implementing Better Births: Continu…

Download PDF Commissioners and providers across England, guided by their MVPs, are working across the country to implement sustainable Continuity of Carer models of care,…

Read more